Cargando…

The effect of adverse and positive experiences on inflammatory markers in Australian and UK children

BACKGROUND: The relationship between childhood adversity and inflammation is well-established. Examination of positive experiences can provide a more complete understanding of intervention opportunities. We investigated associations of adverse and positive experiences, and their intersection, with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Priest, Naomi, Guo, Shuaijun, Gondek, Dawid, Lacey, Rebecca E., Burgner, David, Downes, Marnie, Slopen, Natalie, Goldfeld, Sharon, Moreno-Betancur, Margarita, Kerr, Jessica A., Cahill, Stephanie, Wake, Melissa, Juonala, Markus, Lycett, Kate, O'Connor, Meredith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677086/
https://www.ncbi.nlm.nih.gov/pubmed/36420372
http://dx.doi.org/10.1016/j.bbih.2022.100550
Descripción
Sumario:BACKGROUND: The relationship between childhood adversity and inflammation is well-established. Examination of positive experiences can provide a more complete understanding of intervention opportunities. We investigated associations of adverse and positive experiences, and their intersection, with inflammation in children and adolescents. METHODS: Data sources: Longitudinal Study of Australian Children (LSAC; N = 1237) and Avon Longitudinal Study of Parents and Children (ALSPAC; N = 3488). Exposures: Adverse and positive experiences assessed repeatedly (LSAC: 0–11 years; ALSPAC: 0–15 years). Outcomes: Inflammation quantified by high sensitivity C-reactive protein (hsCRP) and glycoprotein acetyls (GlycA) (LSAC: 11–12 years; ALSPAC: 15.5 years). Analyses: Linear regression on the log-transformed outcomes estimated the relative difference in inflammatory markers with adverse/positive experiences, adjusting for socio-demographics and concurrent positive/adverse experiences, respectively. RESULTS: Most associations were in the expected direction but differed in magnitude by exposure, outcome and cohort. Across both cohorts, adverse experiences were associated with up to 7.3% higher hsCRP (95% CI: −18.6%, 33.2%) and up to 2.0% higher GlycA (95% CI: 0.5%, 3.5%); while positive experiences were associated with up to 22.1% lower hsCRP (95% CI: −49.0%, 4.7%) and 1.3% lower GlycA (95% CI: −2.7%, 0.2%). In LSAC, the beneficial effect of positive experiences on inflammation was more pronounced among those with fewer concurrent adverse experiences. CONCLUSION: Across two cohorts, we found small but directionally consistent associations between adverse experiences and higher inflammation, and positive experiences and lower inflammation, particularly for GlycA. Future research should give further consideration to positive experiences to complement the current focus on adversity and inform the design and evaluation of early life interventions.